These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 18365767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
    Cahill MT, Banks AD, Stinnett SS, Toth CA.
    Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quality of Vision Index: a new method to appraise visual function changes in age-related macular degeneration.
    Piermarocchi S, Varano M, Parravano M, Oddone F, Sartore M, Ferrara R, Sera F, Virgili G.
    Eur J Ophthalmol; 2011 Jan; 21(1):55-66. PubMed ID: 20640999
    [Abstract] [Full Text] [Related]

  • 6. Quality of life among patients with age-related severe macular degeneration assessed using the NEI-VFQ, HADS-A, HADS-D and SF-36 tests. A cross-sectional study.
    Inan S, Cetinkaya E, Duman R, Dogan I, Inan UÜ.
    Sao Paulo Med J; 2019 May 08; 137(1):25-32. PubMed ID: 31116266
    [Abstract] [Full Text] [Related]

  • 7. Comparison of vision-related quality of life in primary open-angle glaucoma and dry-type age-related macular degeneration.
    Karadeniz Ugurlu S, Kocakaya Altundal AE, Altin Ekin M.
    Eye (Lond); 2017 Mar 08; 31(3):395-405. PubMed ID: 27813519
    [Abstract] [Full Text] [Related]

  • 8. The MacDQoL individualized measure of the impact of macular degeneration on quality of life: reliability and responsiveness.
    Mitchell J, Wolffsohn J, Woodcock A, Anderson SJ, Ffytche T, Rubinstein M, Amoaku W, Bradley C.
    Am J Ophthalmol; 2008 Sep 08; 146(3):447-454. PubMed ID: 18547542
    [Abstract] [Full Text] [Related]

  • 9. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
    Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA.
    Ophthalmology; 2005 Jan 08; 112(1):144-51. PubMed ID: 15629835
    [Abstract] [Full Text] [Related]

  • 10. Age-Related Macular Degeneration and Quality of Life in Latinos: The Los Angeles Latino Eye Study.
    Choudhury F, Varma R, Klein R, Gauderman WJ, Azen SP, McKean-Cowdin R, Los Angeles Latino Eye Study Group.
    JAMA Ophthalmol; 2016 Jun 01; 134(6):683-90. PubMed ID: 27124819
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.
    Lindblad AS, Clemons TE.
    Arch Ophthalmol; 2005 Sep 01; 123(9):1207-14. PubMed ID: 16157800
    [Abstract] [Full Text] [Related]

  • 13. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population.
    Jelin E, Wisløff T, Moe MC, Heiberg T.
    Health Qual Life Outcomes; 2019 Aug 14; 17(1):140. PubMed ID: 31412873
    [Abstract] [Full Text] [Related]

  • 14. Relationships between retinal structure and function and vision-related quality of life measures in advanced age-related macular degeneration.
    Sabeti F, Lane J, Rohan EMF, Essex RW, McKone E, Maddess T.
    Graefes Arch Clin Exp Ophthalmol; 2021 Dec 14; 259(12):3687-3696. PubMed ID: 34236475
    [Abstract] [Full Text] [Related]

  • 15. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
    Revicki DA, Rentz AM, Harnam N, Thomas VS, Lanzetta P.
    Invest Ophthalmol Vis Sci; 2010 Feb 14; 51(2):712-7. PubMed ID: 19797233
    [Abstract] [Full Text] [Related]

  • 16. Improving function in age-related macular degeneration: a randomized clinical trial.
    Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Ho AC, Tasman WS.
    Ophthalmology; 2013 Aug 14; 120(8):1649-55. PubMed ID: 23642378
    [Abstract] [Full Text] [Related]

  • 17. Vision-related quality of life in patients suffering from age-related macular degeneration.
    Berdeaux GH, Nordmann JP, Colin E, Arnould B.
    Am J Ophthalmol; 2005 Feb 14; 139(2):271-9. PubMed ID: 15733988
    [Abstract] [Full Text] [Related]

  • 18. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators.
    Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD.
    Arch Ophthalmol; 1998 Nov 14; 116(11):1496-504. PubMed ID: 9823352
    [Abstract] [Full Text] [Related]

  • 19. Vision-related quality of life in patients with diabetic macular oedema.
    Hariprasad SM, Mieler WF, Grassi M, Green JL, Jager RD, Miller L.
    Br J Ophthalmol; 2008 Jan 14; 92(1):89-92. PubMed ID: 17584999
    [Abstract] [Full Text] [Related]

  • 20. Impact of age related macular degeneration on quality of life.
    Hassell JB, Lamoureux EL, Keeffe JE.
    Br J Ophthalmol; 2006 May 14; 90(5):593-6. PubMed ID: 16622089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.